CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale SVP, Chief Legal Officer sold 63,186 shares at $1.22 ($77,270)
- 4 Open-market sale SVP, Chief Operating Officer sold 95,478 shares at $1.22 ($116,760)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Other events
- 4 Open-market sale SVP, Chief Medical Officer sold 63,567 shares at $1.07 ($67,890)
- 4 Open-market sale SVP, CFO and Treasurer sold 63,567 shares at $1.07 ($67,890)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award SVP, Chief Legal Officer acquired 100,000 shares (grant or award)
Page 11 of 45 · 886 filings